Company record

nPhase, Inc.

Unifies and governs clinical data to provide an AI-ready foundation for pharmaceutical sponsors and CROs. nphase.ai

Funding

Of the 5 Series D rounds with exactly stated amounts in dollars on Presspool's weekly rosters since September 21, 2026, nPhase, Inc.'s $30 million is the smallest; their median is $130 million.

Whether AI names nPhase, Inc.

A company counts when an AI answer names it or cites its website. Answers vary from run to run, so each count is a dated sample.

Related records

Closest rounds in the roster for November 2–7, 2026: Larridin ($30 million Series A, November 2, 2026), Lazarus AI ($43 million, round type not disclosed, November 3, 2026), Humble Robotics ($51 million Series A, November 5, 2026), firmly ($15 million Series A, November 5, 2026), Guava ($12.5 million Seed, November 3, 2026), Kalepa ($75 million Series B, November 5, 2026).

Sources

Every fact on this page links its source. Corrections need a public source: see Contact.